Arkansas Best Corporation (ABFS) - FREE Research Report

Johns Michael R who is VP - Gen Counsel & Corp Sec at Arkansas Best Corporation sold 5,000 shares at $32.45 on Nov. 19, 2013. Following this transaction, the VP - Gen Counsel & Corp Sec owned 36,641 shares meaning that the stake was reduced by 12.01% with the 5,000 share transaction.

The shares most recently traded at $31.94, down $0.51, or 1.6% since the insider transaction. Historical insider transactions for Arkansas Best Corporation go as follows:

  • 12-Week # shares sold: 6,952
  • 24-Week # shares sold: 6,952

The average volume for Arkansas Best Corporation has been 551,400 shares per day over the past 30 days. Arkansas Best Corporation has a market cap of $824.9 million and is part of the services sector and transportation industry. Shares are up 235.71% year to date as of the close of trading on Tuesday.

Arkansas Best Corporation, through its subsidiaries, provides freight transportation services and solutions. The stock currently has a dividend yield of 0.37%. Currently there are 2 analysts that rate Arkansas Best Corporation a buy, 1 analyst rates it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ABFS - FREE

TheStreet Quant Ratings rates Arkansas Best Corporation as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and poor profit margins. Get the full Arkansas Best Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Facebook and Snap Have One Issue That Will Have to Be Solved: Peter Bonfield

10 Biggest Takeaways from Apple's iPhone X Event

Google Pixel 2 Debuting October 4, FYI Apple

The iPhone X Highlights This Overlooked Strength of Apple's

Arconic, Idexx Laboratories, AbbVie: 'Mad Money' Lightning Round